Search research articles
Contact Us
Filters
Showing results (181-190 of 226) with videos related to
Page
of 23
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
April 1, 1985
The earplug procedure
J W Thelin, W E Davis, J Khoury-Ghaffary, et al.
Journal of Neurovirology
|
April 27, 2012
Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion
Nicole A Renner, Hope A Sansing, Lisa A Morici, et al.
Journal of Neurovirology
|
June 28, 2014
Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS
Kim M Lee, Kevin B Chiu, Nicole A Renner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 16, 2011
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
L Klimek, J Willers, A Hammann-Haenni, et al.
Journal of Cellular Physiology
|
November 17, 2012
Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes
Nicole A Renner, Hope A Sansing, Fiona M Inglis, et al.
Intervirology
|
February 5, 2003
Virus-like particles as a modular system for novel vaccines
Franziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
Advances in Hematology
|
June 25, 2026
Incidence of Induction Toxicities in Childhood Acute Lymphoblastic Leukaemia in Ghana
Lily Gloria Tagoe, Emmanuella Amoako, Ernestina Schandorf, et al.
Journal of Analytical Toxicology
|
February 14, 2008
Validation and application of a GC-MS method for determining soman concentration in rat plasma following low-level vapor exposure
Julie A Renner, Paul A Dabisch, Ronald A Evans, et al.
European Journal of Immunology
|
June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity
Patrik Maurer, Gary T Jennings, Jörg Willers, et al.
Virology Journal
|
December 23, 2009
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein
Roger R Beerli, Monika Bauer, Nicole Schmitz, et al.
Page
of 23
Search research articles
Search
Showing results (181-190 of 226) with videos related to
Sort By:
Page
of 23
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
April 1, 1985
The earplug procedure
J W Thelin, W E Davis, J Khoury-Ghaffary, et al.
Journal of Neurovirology
|
April 27, 2012
Microglia activation by SIV-infected macrophages: alterations in morphology and cytokine secretion
Nicole A Renner, Hope A Sansing, Lisa A Morici, et al.
Journal of Neurovirology
|
June 28, 2014
Form follows function: astrocyte morphology and immune dysfunction in SIV neuroAIDS
Kim M Lee, Kevin B Chiu, Nicole A Renner, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology
|
June 16, 2011
Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
L Klimek, J Willers, A Hammann-Haenni, et al.
Journal of Cellular Physiology
|
November 17, 2012
Transient acidification and subsequent proinflammatory cytokine stimulation of astrocytes induce distinct activation phenotypes
Nicole A Renner, Hope A Sansing, Fiona M Inglis, et al.
Intervirology
|
February 5, 2003
Virus-like particles as a modular system for novel vaccines
Franziska Lechner, Andrea Jegerlehner, Alain C Tissot, et al.
Advances in Hematology
|
June 25, 2026
Incidence of Induction Toxicities in Childhood Acute Lymphoblastic Leukaemia in Ghana
Lily Gloria Tagoe, Emmanuella Amoako, Ernestina Schandorf, et al.
Journal of Analytical Toxicology
|
February 14, 2008
Validation and application of a GC-MS method for determining soman concentration in rat plasma following low-level vapor exposure
Julie A Renner, Paul A Dabisch, Ronald A Evans, et al.
European Journal of Immunology
|
June 23, 2005
A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity
Patrik Maurer, Gary T Jennings, Jörg Willers, et al.
Virology Journal
|
December 23, 2009
Prophylactic and therapeutic activity of fully human monoclonal antibodies directed against influenza A M2 protein
Roger R Beerli, Monika Bauer, Nicole Schmitz, et al.
Page
of 23